Acadia Pharmaceuticals, a leader in neuroscience and rare disease, is working to advance next-generation therapies. The company's commercial portfolio already includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. Acadia is also developing the next wave of therapeutic advancements with a pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. 

Catherine Owen Adams, the CEO of Acadia, discusses her firm's commitment to turning scientific promise into meaningful innovation that can help make a difference for underserved neurological and rare disease communities around the world. Catherine speaks with Tim Stenovec and Emily Graffeo on Bloomberg Businessweek Daily.

Acadia Pharmaceuticals, a leader in neuroscience and rare disease, is working to advance next-generation therapies. The company's commercial portfolio already includes the first and only FDA-approved treatments for Parkinson&rsquo;s disease psychosis and Rett syndrome. Acadia is also developing the next wave of therapeutic advancements with a pipeline that includes mid- to late-stage programs in Alzheimer&rsquo;s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. Catherine Owen Adams, the CEO of Acadia, discusses her firm's commitment to turning scientific promise into meaningful innovation that can help make a difference for underserved neurological and rare disease communities around the world. Catherine speaks with Tim Stenovec and Emily Graffeo on Bloomberg Businessweek Daily.

Carol Massar and Tim Stenovec bring you reporting from the magazine that helps global leaders stay ahead, plus insight on the people, companies and trends shaping today's complex economy.  Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

Carol Massar and Tim Stenovec bring you reporting from the magazine that helps global leaders stay ahead, plus insight on the people, companies and trends shaping today's complex economy.&nbsp; Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Acadia CEO on the Fight Against Rare Diseases

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c8f87c67-dee7-4e9f-bef0-b3d1017527cf/transcript